Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-VEGFR2 antibody therapy for hepatocellular carcinoma

Anti-VEGFR2 antibody therapy for hepatocellular carcinoma

US Patent 10766961 · Granted Sep 8, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Trifluoromethyl-substituted sulfonamide as BCL-2-selective inhibitor2025
Drug combination containing TLR7 agonist2025
TLR7 agonist for treating colorectal cancer and pharmaceutical combination there2025
Coating composition2025
Coating composition2024
TLR7 agonist and pharmaceutical combination thereof for treating lung cancer2024
Iminosulfanone compound as bromodomain protein inhibitor and pharmaceutical comp2024
Apparatus and method for treating waste water containing ammonium salts2023
Apparatus and method for treating waste water containing ammonium salts2023
Anti-HBVtetrahydroisoxazolo[4,3-c]pyridine compounds2023
Quinoline derivative for treatment of triple-negative breast cancer2023
Sulfonyl substituted bicyclic compound which acts as ROR inhibitor2022